Clinical trial
Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
NCT00241241 · PV-Nord, Other · Completed
Key facts
| NCT number | NCT00241241 |
|---|---|
| Title | Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera |
| Official title | Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients |
| Lead sponsor | PV-Nord, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Polycythemia Vera |
| Intervention type | Drug |
| Interventions | pegylated interferon-alfa 2a |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2008 |
| First posted | Oct 18, 2005 |
| Last update posted | Oct 21, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: